Prolyl hydroxylase domain inhibitors prevent kidney crystal formation by suppressing inflammation
Crossref DOI link: https://doi.org/10.1007/s00240-024-01677-x
Published Online: 2024-12-26
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kawase, Kengo
Hamamoto, Shuzo
Unno, Rei
Taguchi, Kazumi
Okada, Atsushi
Yasui, Takahiro
Text and Data Mining valid from 2024-12-26
Version of Record valid from 2024-12-26
Article History
Received: 23 October 2024
Accepted: 1 December 2024
First Online: 26 December 2024
Declarations
:
: The authors declare no competing interests.